3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Rituximab
16
Cyclophosphamide
10
Lenalidomide
8
venetoclax
7
Magnetic Resonance Spectroscopy
7
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
Prednisone
5
CT-P10
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Vincristine
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Mycophenolic Acid
3
Doxorubicin
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Etoposide
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
trastuzumab biosimilar HLX02
×
90 days
×
Clear all
No trials found.